Accounting for Time‐Varying Confounding in a Self‐Controlled Case Series of Fluoroquinolone Treatment for Uncomplicated Urinary Tract Infections and Risk of Collagen‐Related Events
Pharmacology Research & Perspectives · 2025
DOI: 10.1002/prp2.70124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Anna Schultze und 5 weiteren Autor:innen. Beteiligte Einrichtung: London School of Hygiene and Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: Fluoroquinolones, Urinary Tract Infections, Anti-Bacterial Agents, Retinal Detachment. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK Internal study number.
Abstract (Originalsprache)
We report findings from three SCCS conducted to quantify the association between fluoroquinolone (FQ) use for the treatment of uncomplicated urinary tract infection (uUTI) and tendon rupture, retinal detachment, and uveitis. Female patients aged ≥ 12 years old in the Optum Clinformatics Data Mart database with an outcome of interest and exposure to either oral FQ or trimethoprim/sulfamethoxazole (SXT) in the 5 days following a newly reported uUTI during the study period (01/01/2011–02/10/2019) were included. We considered a 90‐day risk window for each outcome following drug exposure. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were estimated using conditional Poisson regression, adjusting for age and calendar time, incorporating SXT as an active comparator. We found little evidence of an association between FQ use compared to SXT and any of the outcomes of interest (tendon rupture: IRR = 1.01, 95% CI = 0.91–1.21; retinal detachment: IRR = 0.99, 95% CI = 0.86–1.14; and uveitis: IRR = 1.09, 95% CI = 0.97–1.22). Incorporating the active comparator using two different methods did not change conclusions. The lack of evidence for an association between short‐term use of FQ and the comparator antibiotic (SXT) for the treatment of uUTI and collagen‐related events also implies that there was no marked association between uUTI and these outcomes. However, power was limited, and a small increased risk cannot be ruled out. Using active comparators in SCCS can improve the robustness of studies of antibiotics and adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- London School of Hygiene and Tropical Medicine, London, UK.
- GSK, Brentford, UK.
- GSK, Collegeville, Pennsylvania, USA.
ORCID-Profile: Anna Schultze
Förderung
- GSK Internal study number
Zitieren
APA
Schultze, A., Ju, S., Drysdale, M., Mu, G., Mitrani-Gold, F. S., & Logie, J. (2025). Accounting for Time‐Varying Confounding in a Self‐Controlled Case Series of Fluoroquinolone Treatment for Uncomplicated Urinary Tract Infections and Risk of Collagen‐Related Events. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70124
Vancouver
Schultze A, Ju S, Drysdale M, Mu G, Mitrani-Gold FS, Logie J. Accounting for Time‐Varying Confounding in a Self‐Controlled Case Series of Fluoroquinolone Treatment for Uncomplicated Urinary Tract Infections and Risk of Collagen‐Related Events. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70124
BibTeX
@article{Schultze2025,
author = {Schultze, Anna and Ju, Shinyoung and Drysdale, Myriam and Mu, George and Mitrani-Gold, Fanny S and Logie, John},
title = {Accounting for Time‐Varying Confounding in a Self‐Controlled Case Series of Fluoroquinolone Treatment for Uncomplicated Urinary Tract Infections and Risk of Collagen‐Related Events},
journal = {Pharmacology Research & Perspectives},
year = {2025},
doi = {10.1002/prp2.70124}
}
EUVIMED